BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 6980250)

  • 1. S-Adenosylhomocysteine accumulation and selective cytotoxicity in cultured T- and B-lymphocytes.
    Palella TD; Schatz RA; Wilens TE; Fox IH
    J Lab Clin Med; 1982 Aug; 100(2):269-78. PubMed ID: 6980250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered cell cycle distributions of cultured human lymphoblasts during cytotoxicity related to adenosine deaminase inhibition.
    Faller J; Palella TD; Dean P; Fox IH
    Metabolism; 1984 Apr; 33(4):369-74. PubMed ID: 6608657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-adenosylhomocysteine hydrolase inactivation and purine toxicity in cultured human T- and B-lymphoblasts.
    Young GJ; Hallam LJ; Jack I; Van Der Weyden MB
    J Lab Clin Med; 1984 Jul; 104(1):86-95. PubMed ID: 6330251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection and characterization of a murine lymphoid cell line partially deficient in S-adenosylhomocysteine hydrolase.
    Kamatani N; Willis EH; Carson DA
    Biochim Biophys Acta; 1983 Apr; 762(2):205-14. PubMed ID: 6600937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased methionine synthesis in purine nucleoside-treated T and B lymphoblasts and reversal by homocysteine.
    Boss GR; Pilz RB
    J Clin Invest; 1984 Oct; 74(4):1262-8. PubMed ID: 6332827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-adenosylhomocysteine toxicity in normal and adenosine kinase-deficient lymphoblasts of human origin.
    Kredich NM; Hershfield MS
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2450-4. PubMed ID: 221926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation.
    Hershfield MS; Kredich NM
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4292-6. PubMed ID: 6254019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
    Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
    Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 2'-deoxycoformycin infusion on S-adenosylhomocysteine hydrolase and the amount of S-adenosylhomocysteine and related compounds in tissues of mice.
    Helland S; Ueland PM
    Cancer Res; 1983 Sep; 43(9):4142-7. PubMed ID: 6603264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine metabolism: modification by S-adenosylhomocysteine and 5'-methylthioadenosine.
    Fox IH; Palella TD; Thompson D; Herring C
    Arch Biochem Biophys; 1982 Apr; 215(1):302-8. PubMed ID: 6807209
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
    Bagnara AS; Hershfield MS
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients.
    Hershfield MS; Kredich NM; Ownby DR; Ownby H; Buckley R
    J Clin Invest; 1979 Apr; 63(4):807-11. PubMed ID: 312296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-Adenosylhomocysteine metabolism in adenosine deaminase deficient cells.
    Hershfield MS; Kredich NM
    Adv Exp Med Biol; 1980; 122A():421-5. PubMed ID: 7424659
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of S-adenosylhomocysteine hydrolase in adenosine metabolism in mammalian heart.
    Schrader J; Schütz W; Bardenheuer H
    Biochem J; 1981 Apr; 196(1):65-70. PubMed ID: 7306081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of T cell activation by an inhibitor of S-adenosyl-L-homocysteine hydrolase.
    Wolos JA; Frondorf KA; Davis GF; Jarvi ET; McCarthy JR; Bowlin TL
    J Immunol; 1993 Apr; 150(8 Pt 1):3264-73. PubMed ID: 8468468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 9-beta-D-arabinofuranosyladenine and erythro-9-(2-hydroxy-3-nonyl) adenine on the metabolism of S-adenosylhomocysteine, S-adenosylmethionine, and adenosine in rat liver.
    Eloranta TO; Kajander EO; Raina AM
    Med Biol; 1982 Oct; 60(5):272-7. PubMed ID: 7154718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of methylation by adenosine in adenosine deaminase-inhibited, phytohemagglutinin-stimulated human lymphocytes.
    Johnston JM; Kredich NM
    J Immunol; 1979 Jul; 123(1):97-103. PubMed ID: 448160
    [No Abstract]   [Full Text] [Related]  

  • 19. Purine deoxynucleosides and adenosine dialdehyde decrease 5-amino-4-imidazolecarboxamide (Z-base)-dependent purine nucleotide synthesis in cultured T and B lymphoblasts.
    Boss GR
    Biochem J; 1987 Mar; 242(2):425-31. PubMed ID: 3109390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of adenosine deaminase inhibitors on lymphocyte-mediated cytolysis.
    Wolberg G; Zimmerman TP
    Ann N Y Acad Sci; 1985; 451():215-26. PubMed ID: 3878118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.